Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Spagnoli

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Cancer|December 26, 2001
MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumorsF Aubry, A P Satie, N Rioux-Leclercq, et al.
Human Gene Therapy|March 5, 2002
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivoDaniel Oertli, Walter R Marti, Paul Zajac, et al.
Head & Neck|October 2, 2010
High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynxDavid L A Figueiredo, Rui C M Mamede, Giulio C Spagnoli, et al.
Cancer Immunology, Immunotherapy : CII|April 6, 2011
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Sylvia Adams, Luba Greeder, Elsa Reich, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 18, 2002
The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situAnne-Pascale Satie, Ewa Rajpert-De Meyts, Giulio C Spagnoli, et al.
Journal of Translational Medicine|November 14, 2006
Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donorsMaurizio Provenzano, Laura Bracci, Stephen Wyler, et al.
Annals of Surgery|November 28, 2002
Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinomaMartin Bolli, Thomas Kocher, Michel Adamina, et al.
Contemporary Clinical Trials|August 21, 2007
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trialMichel Adamina, Walter P Weber, Rachel Rosenthal, et al.
Journal of Virology|June 1, 2012
Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasiaGiovanni Sais, Stephen Wyler, Tvrtko Hudolin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 24, 2004
Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarrayDhananjay A Chitale, Achim A Jungbluth, David S Marshall, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Cancer|December 26, 2001
MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumorsF Aubry, A P Satie, N Rioux-Leclercq, et al.
Human Gene Therapy|March 5, 2002
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivoDaniel Oertli, Walter R Marti, Paul Zajac, et al.
Head & Neck|October 2, 2010
High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynxDavid L A Figueiredo, Rui C M Mamede, Giulio C Spagnoli, et al.
Cancer Immunology, Immunotherapy : CII|April 6, 2011
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Sylvia Adams, Luba Greeder, Elsa Reich, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 18, 2002
The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situAnne-Pascale Satie, Ewa Rajpert-De Meyts, Giulio C Spagnoli, et al.
Journal of Translational Medicine|November 14, 2006
Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donorsMaurizio Provenzano, Laura Bracci, Stephen Wyler, et al.
Annals of Surgery|November 28, 2002
Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinomaMartin Bolli, Thomas Kocher, Michel Adamina, et al.
Contemporary Clinical Trials|August 21, 2007
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trialMichel Adamina, Walter P Weber, Rachel Rosenthal, et al.
Journal of Virology|June 1, 2012
Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasiaGiovanni Sais, Stephen Wyler, Tvrtko Hudolin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 24, 2004
Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarrayDhananjay A Chitale, Achim A Jungbluth, David S Marshall, et al.
Pageof 19